Bruker CorpBRKR
Price$61.94Intrinsic value$61.820% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $3.5B+4.0% YoYTTM through 30 Jun 2026
Net Income -$71.2M-163.0% YoYTTM through 30 Jun 2026
Free Cash Flow $93.9MTTM through 30 Jun 2026

Margins

Current
Gross Margin46.4%
EBITDA Margin5.7%
Operating Margin1.2%
Net Margin-2.0%

Returns

-4.5%ROE
-0.2%ROA

Balance Sheet Health

Debt / Equity6.77x
Current Ratio1.55x
Net Debt$1.5B
Cash & Equivalents$184.9M

Quality Metrics

Altman Z-Score2.81
Piotroski F-Score4 / 9
FCF Margin2.7%
Rule of 404.3
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $3.4B
Diluted EPS-$0.70TTM
'19'20'21'22'23'24'25
FY2025: $-0.06

Dividend

$0.10Per share, FY20260.35%Yield-9.0%5-yr growth

Capital Allocation

R&D Spend$393.5M
Capex Intensity2.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.